Top Portland, OR Biotech Companies (27)
Don't see your company?
Create a company profile
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started: Improving human health. We are driven by over 10,000 ambitious, passionate people worldwide who are willing to fight like warriors to earn the trust of our customers by listening, serving with integrity, thinking big, and being dependable. We've already changed millions of lives and we're ready to change millions more. Our future ambition is to become a leading consumer health technology company while continuing to develop solutions for serious health conditions. We'll get there by constantly reinventing unique biosensing-technology experiences. Though we've come a long way from our small company days, our dreams are bigger than ever. The opportunity to improve health on a global scale stands before us
AgonOx is a cure for many types of cancer will be found through harnessing the power of the immune system
VALIDY corresponds in the information technologies field to the mechanisms that guarantee the integrity of the DNA of a living cell.
Veana Therapeutics is dedicated to developing innovative, safe, cancer fighting medicines Veana’s VIMO technology is based on orally bioavailable anti-cancer agents that selectively attack and destroy the energy powerhouses (mitochondria) of cancer cells in a fashion that subsequently stimulates the immune system. Veana’s VIMO platform of α-TEA salt form-based products can be combined with other forms of immunotherapy to further improve anti-tumor activity.
Pdx Pharmaceuticals is a Pharmaceutical company located in Portland.
Circumvent Pharmaceuticals is a Pharmaceuticals company.
At BIOTRONIK, patient well-being is our top priority and has been for 60 years. BIOTRONIK is a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated innovators who develop trusted cardiovascular, endovascular and neuromodulation solutions. BIOTRONIK is headquartered in Berlin, Germany, and is represented in over 100 countries. Quality in every detail. From the very start, BIOTRONIK dedicated itself to driving progress and innovation and delivering exceptional quality. We have earned the trust of medical professionals and patients by combining the renowned art of German engineering with technical excellence and uncompromising quality standards. This dedication is evident in everything we do. High achievers are welcome. Medical engineering is an industry of the future. In a field marked by rapid developments and short innovation cycles, the best guarantees for sustainable success are committed, creative, team-oriented specialists, and outstanding leadership. If you are passionate about computer science, engineering or the natural sciences and enjoy developing new ideas, you´ve found the right place. Are you interested? Take a look at our website www.biotronik.com/careers
Rewire Neuroscience is a Portland, Oregon startup, dedicated to empowering the diverse future of science. We develop intelligent technologies to push forward biomedical research. Our goal is to improve the pace, ease, and reproducibility of research. At Rewire, we are committed to building strength by being a diverse team of leaders, innovators, and risk-takers. We’re all different, and that is what allows us to draw on a range of experiences, backgrounds, and perspectives to grow stronger, together. Rewire is a vocal supporter of race, gender, sexual-orientation, and cultural equality.
Blending technology and science, we develop instrumentation to improve outcomes. Araceli Biosciences delivers high-performance scientific tools for tissue and cell-based biomarker discovery, drug discovery and drug development. With decades of combined biomedical research and instrument design experience, we are focused on developing scientific instrumentation to improve outcomes and enable our customers to advance scientific and medical research. Speed is essential for furthering our understanding of biology, and we believe in reducing the time needed to acquire high-quality data and obtain clear, high-quality results. By making advanced technologies accessible, we allow researchers to focus on the science, not the tool. Our goal is to develop innovative products that accelerate basic research, drug discovery, and manufacturing to advance healthy outcomes. We believe in blurring the line between science and technology, using one to improve the other in a holistic approach. We strive to make the drug discovery process more efficient, reducing the time and bandwidth needed to screen compounds. By pairing fast, easy to use hardware with advanced artificial intelligence analysis algorithms, we aim to transform the drug discovery pipeline, allowing customers to fail faster.
AbSci is a leading synthetic biology company that translates ideas into drugs with a platform technology that reinvents the biopharmaceutical drug discovery process.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.
Aronora A biotech company focusing on the development of safer biologic drugs.
DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases.
A Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures.
UbiVac is a clinical stage biotech engaged in research and development, and manufacture, of therapeutic immune activators, vaccines and cellular immunotherapies to combat cancer. Used in combination with other immunotherapies, UbiVac’s patented technologies have proven highly effective at improving survival and apparent cure in difficult to treat animal cancers (PMID: 27874054; PMID: 31747946; PMID: 22068657). UbiVac believes that the explanation for this effectiveness lies in several high impact publications from 2021 identifying a previously unknown class of shared non-mutated cancer neoantigens that make up as much as 25% of the antigens on cancer cells (PMID: 33740418; PMID: 33691108; PMID: 34663921). As the non-mutated shared cancer neoantigens are short-lived proteins, the majority are expected to be contained in UbiVac’s DPV-001. Importantly, these findings help explain why UbiVac’s immunotherapy provided cross-protective cancer immunity in preclinical models, something that had not been observed in 50 years of study (PMID: 21810919). These remarkable studies raised the possibility of off-the-shelf Universal Cancer Vaccines (PMID: 33852826). UbiVac has completed an NCI-funded phase I/II adjuvant trial of its lead agent, DPV-001. This trial met its endpoints, determined safety, identified drug formulation, and demonstrated proof-of-concept. Based on these data UbiVac partnered with the Providence Cancer Institute and Incyte on a first-in-human immunotherapy trial of UbiVac’s DPV-001, anti-GITR and anti-PD-1 for advanced HNSCC. The first patients were treated in Q4 2021, and preliminary immunological monitoring data will be presented at AACR in April 2022. UbiVac also has a pipeline of cellular therapies under development. Given that UbiVac’s CEO and CSO, together, have 55+ years of experience with preclinical and clinical studies of adoptive immunotherapy, UbiVac is well positioned to bring their innovative cellular therapy platforms to the clinic.
What started as a small family business in 1988 has since evolved into a global market leader, providing orthopaedic and medical solutions that improve patient care around the world. Our story begins in Butler, NJ, where Mary and Randy Huebner founded Accurate Machine and Design, also known as Acumed. With only one machinist on staff, Acumed was contracted to engineer implant prototypes for some of the biggest names in the industry. After relocating to Oregon in 1991, we launched our first line of arthroscopy screws intended for ACL ligaments and haven’t looked back since. The successes of the Oregon Fixation Screw allowed Acumed to research, design, and manufacture the majority of our products while adding new lines each year. In 1999, Colson Associates, a division of The Marmon Group, purchased Acumed and provided the capital to purchase new equipment and a new facility to step up our production efforts. Currently Headquartered in Hillsboro, Oregon, with a global distribution network and offices worldwide Acumed is a multi-award-winning company, dedicated to innovative and quality medical device solutions. We are committed to the highest standards of manufacturing and proudly produce over 90% of our implants in the U.S. Throughout our history, Acumed has remained focused on the founders’ original vision of providing innovative solutions to meet the needs of the whole healthcare community, including hospitals, surgeons and patients.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours.
Tricol is focused on saving lives through innovation in hemostasis. Stop the bleed! Tricol Biomedical is a fully integrated medical device company that is dedicated to significantly advancing the standard of care in hemostatic and wound care management. Born on the battlefield, our HemCon product line has grown to meet market needs in Trauma Management, Procedural Care and Consumer Self-Care. We are fully committed to quality and innovation in bleeding control and wound care technology.
MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
Work Your Passion. Live Your Purpose.
